Plain-English translation of NCT07202247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing three different approaches to help prostate cancer patients stay healthy while receiving hormone therapy (androgen deprivation therapy), which can sometimes lead to weight gain and heart problems. One group will try time-restricted eating—eating within a shorter window each day. Another group will take or , medications that can help with weight management. The third group will focus on a heart-healthy diet. Researchers want to see which approach works best at protecting your heart and keeping you feeling well.
Hormone therapy for prostate cancer is an important treatment, but it can cause unwanted side effects like weight gain, high blood sugar, and heart problems. This trial exists to find simple, safe ways to prevent these complications so patients can stay as healthy as possible during their cancer treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to one of three groups for 6 months. One group will fast for 16 hours overnight at least 5 days per week and receive dietary coaching; another will take a weekly injection of medication plus dietary education; and a third will focus on heart-healthy eating guidelines. All participants will have blood tests and CT scans during the study, complete food diaries or surveys using a mobile app, and answer questions about how they're feeling. You'll visit the clinic for regular check-ins throughout the 6 months.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
United States